"/> Novus Biologicals™ Peptide bloquant d’anticorps DP… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps DPYSL4

Réf. : BL-RE-083370Réf. fabricant : 18006779 0.25 mg
331,52 € HT

Highly purified. Generating reliable and reproducible results.

Gene ID (Entrez)
10570
Espèces
Human
Pureté
>85%, by HPLC
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
Sodium Bicarbonate buffer, pH 8.00 containing up to 10% DMSO
Marque
Novus Biologicals

Synthetic peptide corresponding to amino acids 509-527 of human CRMP3. The DPYSL4 Blocking Peptide is derived from Synthetic. The DPYSL4 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-083370
Réf. fabricant18006779
Gene ID (Entrez)10570
EspècesHuman
Pureté>85%, by HPLC
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormuleSodium Bicarbonate buffer, pH 8.00 containing up to 10% DMSO
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP2-11055. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneCRMP-3, CRMP3Collapsin response mediator protein 3, dihydropyrimidinase-like 4, dihydropyrimidinase-related protein 4, DRP-4 UNC33-like phosphoprotein 4, ULIP4ULIP-4
Symbole de gène(s)DPYSL4
Type de produitDPYSL4
Quantité0.25 mg
État réglementaireRUO - research use only
ConsigneBlocking Peptide for NBP2-11055
Une question, une configuration particulière ?
Contactez-nous pour un devis.